Experimental Hematology
Volume 38, Issue 5 , Pages 426-433 , May 2010

Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients

  • Giovanni Caocci

      Affiliations

    • Cattedra di Ematologia, Dipartimento di Scienze Mediche Internistiche, Centro Trapianti Midollo Osseo, Università di Cagliari, Cagliari, Italy
    • Corresponding Author InformationOffprint requests to: Giovanni Caocci, M.D., Centro Trapianti di Midollo Osseo, P.O. “R. Binaghi,” Via Is Guadazzonis 3, 09126 Cagliari, Italy
  • ,
  • Roberto Baccoli

      Affiliations

    • Dipartimento Ingegneria del Territorio−Fisica Tecnica, Facoltà di Ingegneria, Università di Cagliari, Cagliari, Italy
  • ,
  • Adriana Vacca

      Affiliations

    • Cattedra di Ematologia, Dipartimento di Scienze Mediche Internistiche, Centro Trapianti Midollo Osseo, Università di Cagliari, Cagliari, Italy
  • ,
  • Angela Mastronuzzi

      Affiliations

    • Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy
  • ,
  • Alice Bertaina

      Affiliations

    • Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy
  • ,
  • Eugenia Piras

      Affiliations

    • Cattedra di Ematologia, Dipartimento di Scienze Mediche Internistiche, Centro Trapianti Midollo Osseo, Università di Cagliari, Cagliari, Italy
  • ,
  • Roberto Littera

      Affiliations

    • Cattedra di Genetica Medica, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
  • ,
  • Franco Locatelli

      Affiliations

    • Dipartimento di Oncoematologia e Medicina Trasfusionale, IRCCS, Ospedale Bambino Gesù, Rome, Italy
  • ,
  • Carlo Carcassi

      Affiliations

    • Cattedra di Genetica Medica, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
  • ,
  • Giorgio La Nasa

      Affiliations

    • Cattedra di Ematologia, Dipartimento di Scienze Mediche Internistiche, Centro Trapianti Midollo Osseo, Università di Cagliari, Cagliari, Italy

Received 15 December 2009 ,Revised 24 February 2010 ,Accepted 26 February 2010.

References 

  1. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukaemia. N Engl J Med. 1998;228:962–968
  2. Caocci G, Pisu S, Argiolu F, et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant. 2006;37:165–169
  3. Borgna Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89:1187–1193
  4. Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassemia. Lancet. 1982;2:227–229
  5. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990;322:417–421
  6. La Nasa G, Caocci G, Argiolu F, et al. Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant. 2006;36:971–975
  7. Lucarelli G, Giardini C, Angelucci E. Bone marrow transplantation in thalassemia. In:  Winter JN editors. Blood Stem Cell Transplantation. Boston, MA: Kluwer Academic; 1997;p. 305–315
  8. La Nasa G, Littera R, Locatelli F, et al. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients. Biol Blood Marrow Transplant. 2007;13:1358–1368
  9. La Nasa G, Littera R, Locatelli F, et al. The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol. 2007;139:284–288
  10. Littera R, Orrù N, Vacca A, et al. The role of killer immunoglobulin-like receptor (KIR) haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia. Bone Marrow Transplant. 2010 Feb 22. [Epub ahead of print.]
  11. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006;107:2984–2992
  12. Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med. 2000;19:1831–1847
  13. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  14. Schwarzer G, Vach W, Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med. 2000;19:541–561
  15. Linder R, König IR, Weimar C, Diener HC, Pöppl SJ, Ziegler A. Two models for outcome prediction—a comparison of logistic regression and neural networks. Methods Inf Med. 2006;45:536–540
  16. Dreiseitl S, Ohno-Machado L. Logistic regression and artificial neural network classification models: a methodology review. J Biomed Inform. 2002;35:352–359
  17. Schumacher M, Olschewski M, Schwarzer G. Contributions of artificial neural networks to knowledge in clinical medicine—is there evidence for improvement?. Biomed J. 2004;46:39
  18. Bassi P, Sacco E, De Marco V, Aragona M, Volpe A. Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis. BJU Int. 2007;99:1007–1012
  19. Zini G. Artificial intelligence in hematology. Hematology. 2005;10:393–400
  20. Zini G, d'Onofrio G. Neural network in hematopoietic malignancies. Clin Chim Acta. 2003;333:195–201
  21. Amendolia SR, Brunetti A, Carta P, et al. A real-time classification system of thalassemic pathologies based on artificial neural networks. Med Decis Making. 2002;22:18–26
  22. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295–304
  23. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation (second of two parts). N Engl J Med. 1975;292:895–902
  24. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103:1417–1424
  25. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics. 2002;54:221–229
  26. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH. Structure and function of natural killer cell receptors: multiplemolecular solution to self, nonself discrimination. Annu Rev Immunol. 2002;20:853–885
  27. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995;268:405–408
  28. Hansasuta P, Dong T, Thananchai H, et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol. 2004;34:1673–1679
  29. Cook MA, Milligan DW, Fegan CD, et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood. 2004;103:1521–1526
  30. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet. 1993;2:2200
  31. Kalogirou Soteris A. Artificial neural networks in renewable energy systems applications: a review. Renew Sustain Energy Rev. 2001;5:373–401
  32. Demuth H, Beale M, Hagan M. Neural Network Toolbox™ 6. User's Guide. Natick, MA: The MathWorks, Inc; 2008;
  33. Borgna-Pignatti C. Surviving with thalassemia major: the Italian experience. Pediatr Hematol Oncol. 2007;24:75–78
  34. Giardini C, Lucarelli G. Bone marrow transplantation for betathalassemia. Hematol Oncol. Clin North Am. 1999;13:1059–1064
  35. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993;329:840–844
  36. Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann NY Acad Sci. 1998;850:270–275
  37. Lucarelli G, Clift R, Galimberti M, et al. Bone marrow transplantation in adult thalassemic patients. Blood. 1999;93:1164–1167
  38. La Nasa G, Argiolu F, Giardini C, et al. Unrelated bone marrow transplantation for beta-thalassemia patients: the experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci. 2005;1054:186–195
  39. Bernardo ME, Zecca M, Piras E, et al. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. Br J Haematol. 2008;143:548–551
  40. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105:4878–4884
  41. Paczesny S, Hanauer D, Sun Y, Reddy P. New perspectives on the biology of acute GVHD. Bone Marrow Transplant. 2010;45:1–11

PII: S0301-472X(10)00077-9

doi: 10.1016/j.exphem.2010.02.012

Experimental Hematology
Volume 38, Issue 5 , Pages 426-433 , May 2010